Novilase ILT is an image-guided, minimally invasive alternative for lumpectomy used to ablate small breast tumors. The new clinical trial is the first stage of a two-stage study as part of a U.S. Food and Drug Administration premarket approval (PMA) process, according to Novian Health.
Researchers will evaluate the rate of complete tumor ablation of breast cancers that are up to 2 cm, as well as the correlation of the pathology of postablation lumpectomy specimens with MRI, mammography, and ultrasound in detecting any residual tumor, the firm said. The first facility to participate in the trial is Rose Breast Center of Denver, CO.If you like this content, please share it with a colleague!
Copyright © 2012 AuntMinnie.com